Name: KNSA Balance Sheet - Kiniksa Pharmaceuticals International Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

KNSA - Kiniksa Pharmaceuticals International, PLC

USD | NASDAQ | Healthcare

KNSA Balance Sheet - Kiniksa Pharmaceuticals International Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Cash And Short Term Investments
Cash And Equivalents	165.6	183.6	108.0	122.7	-	114.0	46.9	72.0	45.6	-
Restricted Cash	-	-	0.0	0.0	-	0.2	-	-	0.1	-
Short Term Investments	248.5	60.0	98.4	67.9	-	209.4	186.5	235.3	-	-
Cash And Short Term Investments	414.1	243.6	206.4	190.6	-	323.5	233.4	307.3	45.6	-
Receivables
Accounts Receivable	15.6	41.7	21.3	12.7	-	-	-	-	-	-
Current Assets
Inventory	54.9	26.4	31.1	21.6	-	-	-	-	-	-
Prepaid Expenses	42.6	20.1	17.5	10.5
Non-Current Assets
Property, Plant & Equipment Gross	9.2	8.9	8.5	8.5	-	8.8	8.7	6.7	0.2	-
Accumulated Depreciation	7.2	8.2
Current Liabilities
Accounts Payable	2.0	2.0	8.2	7.9	-	0.5	5.7	10.9	1.2	-
Short Term Debt	-	-	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	6.5	7.9	10.0
Common Equity
Common Stock	-	-	-	-	-	-	-	-	-	-
Additional Paid In Capital	1,029.7	959.7	916.8	888.1
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-
Net debt	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q4 FY 16
Cash And Short Term Investments
Cash And Equivalents	190.0	165.6	174.9	192.0	157.1	183.6	97.4	99.3	141.1	108.0	117.8	112.6	80.6	122.7	175.8

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Receivables
Accounts Receivable	23.2	15.6	51.7	31.9	40.1	41.7	24.9	20.5	16.0	21.3	3.0	24.7	7.4	12.7	11.2	7.8	29.4	-	3.2	2.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Current Assets
Inventory	73.1	54.9	41.4	48.2	22.1	26.4	28.7	34.9	27.3	31.1	25.6	24.0	23.4	21.6	14.6	19.9	13.2	-	5.6	6.4	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	29.7	42.6	30.3	32.4	25.4	20.1	34.0	27.0	13.8	17.5	26.4	12.4	13.2	10.5	15.3	14.0	10.5	-
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	594.2	527.2	475.5	420.3	355.9	331.8	311.3	301.0	270.6	276.3	256.1	246.0	231.5	243.1	241.8	179.9

Non-Current Assets
Property, Plant & Equipment Gross	9.4	9.2	9.5	8.9	8.4	8.9	8.7	8.6	8.7	8.5	8.7	8.6	8.5	8.5	8.6	8.6	8.7	-	9.0	8.9	8.8	8.7	8.7	8.7	8.7	8.2	7.7	-	6.7	2.4	0.4	-	0.2	-
Accumulated Depreciation	7.4	7.2	7.8	7.8	7.8	8.2	8.1	8.0	7.9	7.8	7.7	7.4	7.1	6.9	6.6	6.4	6.3
Property,Plant & Equipment Net	2.0	1.9	1.7	1.1	0.6	0.7	0.6	0.6	0.7	0.7	0.9	1.1	1.4	1.7	2.0	2.2	2.5
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	15.0	15.3	15.5	15.8	16.0	16.3	16.5	16.8	17.0	17.3	17.5	17.8	18.0	18.3	18.5	18.8	19.0
Operating Lease Right Of Use Assets	9.3	9.8	10.1	10.3	10.5	10.4	11.1	11.8	12.3	11.9	12.7	13.2	5.2	5.4	6.2	4.1
Deferred Tax Assets	193.6	198.1	201.3	205.5	208.2	211.2	208.0	204.3	214.9	219.3	193.6	203.9	184.4	185.5	185.8	-	-
Other Non-Current Assets	11.2	11.3	8.3	8.2	8.2	10.3	7.9	7.9	4.1	0.8	2.3	2.4	2.3	5.8	5.6	5.7	5.9
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	825.3	763.6	712.3	661.2	599.3	580.6	555.3	542.4	519.7	526.3	483.1	484.3	442.9	459.7	460.0	210.6	231.0

Current Liabilities
Accounts Payable	24.4	2.0	6.2	9.0	2.0	2.0	8.3	7.4	5.6	8.2	1.0	0.6	1.4	7.9	1.5	2.5	3.4	-	1.6	4.2	0.5	3.9	2.4	4.3	5.7	6.4	9.3	-	10.9	4.7	0.6	-	1.2	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	0.0	0.2	0.3	2.6	4.7	6.5	-	12.1	-	-
Operating Lease Liabilities Current	3.2	3.0	2.7	2.5	2.3	2.0	2.0	2.1	2.3	2.3	2.3	2.2	3.5	3.3	3.3	3.3
Accrued Expenses	32.8	42.0	30.9	36.0	22.1	32.4	40.4	33.4	44.7	27.7	41.1	35.3	20.9	30.1	30.9	34.5	38.9	-
Other Current Liabilities	20.7	22.1	20.5	18.0	17.1	16.1	16.1	11.5	11.4	8.2	6.4	4.6	4.3	5.8	8.8	3.2	4.8
Total Current Liabilities	156.6	139.2	123.6	117.8	97.3	100.6	96.0	84.3	64.2	63.7	53.5	47.5	36.6	47.1	56.5

Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	5.9	6.5	7.0	7.2	7.6	7.9	8.6	9.3	9.9	10.0	10.7	11.3	2.1	2.6	3.4	1.3
Deferred Revenue Non-Current	31.8	31.8	31.8	31.8	31.8	31.8	11.8	11.8	11.8	12.0	11.9	12.0	12.2	12.0	14.2	12.0
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	25.3	18.5	14.5	9.3	5.1	1.8	2.0	1.9	1.9	1.9	1.9	1.9	1.9	1.8	1.8	0.3
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	219.6	196.0	177.0	166.1	141.8	142.1	118.3	107.3	87.8	87.5	77.9	72.7	52.8	63.5	75.9	57.1